Chile - Hospital Average Length of Stay for Carcinoma in Situ
Since 2014, Chile Hospital Average Length of Stay for Carcinoma in Situ was down by 4.1% year on year. In 2019, the country was number 25 among other countries in Hospital Average Length of Stay for Carcinoma in Situ with 2.6 Days. Chile is overtaken by New Zealand, which was ranked number 24 at 2.7 Days and is followed by Mexico with 2.5 Days. South Korea topped the ranking with 7.5 Days in 2019, -2.6% versus 2018. Slovakia, Latvia and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +10.6% per year, while New Zealand was the worst growing country at -8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 2.60 |
| 2018 | 2.70 |
| 2017 | 2.60 |
| 2016 | 3.10 |
| 2015 | 3.20 |
Download all data from 2001 to 2019
How does Chile rank in Hospital Average Length of Stay for Carcinoma in Situ?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
7.50 | 2019 | -2.6 % | +0.8 % | View data | |
| 2 |
#2
Slovakia
|
5.40 | 2019 | +0.0 % | +0.4 % | View data | |
| 24 |
#24
New Zealand
|
2.70 | 2019 | -3.6 % | -8.0 % | View data | |
| 25 |
#25
Chile
|
2.60 | 2019 | -3.7 % | -4.1 % | View data | |
| 26 |
#26
Australia
|
2.50 | 2019 | +0.0 % | -1.5 % | View data | |